GSK plc
New York Stock Exchange•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Ms. Emma Natasha Walmsley
- Full Time Employees
- 70,212
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- Address
- 980 Great West Road Brentford United Kingdom TW8 9GS
- IPO Date
- Mar 28, 1980
- CIK
- 0001131399
- Website
- gsk.com
- Similar Companies
- Business
- GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. The company was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. GSK plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Company News
GSK Reports Sustained Efficacy of RSV Vaccine Amidst Competition from Pfizer and Moderna
RSV Vaccine Demand Drops Sharply in the US, Impacting GSK's Sales
GSK, Pfizer RSV vaccine sales fall in US as millions fewer people line up
GSK RSV shot 43% effective against severe disease in third year
Pfizer wins bid to invalidate GSK's patents over RSV vaccine
Sanofi, GSK, CSL tapped to expand US bird flu vaccine supply, Bloomberg News reports
GSK: Does RSV jab work too well?
3 'Repeatable' Biotech Trades
Why GSK (GSK) is a Top Value Stock for the Long-Term
GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
GSK settles two California lawsuits related to heartburn drug Zantac
GSK's RSV vaccine meets main goal when co-administered with shingles shot
GSK Announces Positive Topline Data on Co-Administration of AREXVY and SHINGRIX
Brooke Shields Partners with GSK to Educate Adults 50 and Older About Their Shingles Risk
Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer
GSK cancer drugs fast-tracked by Chinese
GSK's HSV Vaccine Study Fails to Meet Primary Efficacy Goal
CureVac Partner GSK Announces Positive Phase 2 Data from Seasonal Influenza mRNA Vaccine Program
GSK enjoys success with mRNA flu vaccine trial
GSK's mRNA flu vaccine programme to proceed to late-stage trials